Literature DB >> 7273344

Development of hepatocellular carcinomas and increased peroxisomal fatty acid beta-oxidation in rats fed [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio] acetic acid (Wy-14,643) in the semipurified diet.

N D Lalwani, M K Reddy, S A Qureshi, J K Reddy.   

Abstract

To eliminate interference by contaminating xenobiotics that may possibly be present in the commercial rodent chow, we used semipurified diet in these studied to establish the carcinogenicity of hepatic peroxisome proliferator [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio] acetic acid (Wy-14,643). This compound was fed to male F344 rats in the semipurified diet at a dietary concentration of 0.2% (w/w) for 65 weeks. Between 40 and 65 weeks, 14 of 14 rats fed Wy-14,643 developed hepatocellular carcinomas. Therefore, the possibility that peroxisome proliferators increase the liver tumor incidence by as promoting effect appears highly unlikely, even though these compounds appear to be non-genotoxic. The liver tumors, as well as non-tumor portions of liver in Wy-14,643 fed rats, showed increased levels of peroxisomal fatty acid beta-oxidation system and H2O2. Excessive accumulation of autofluorescent lipofuscin, indicative of increased lipid peroxidation, was also observed in the liver parenchymal cells, during Wy-14,643 induced liver tumorigenesis. These observations support the contention that sustained proliferation of peroxisomes leads to oxygen radical toxicity, which may eventually lead to the development of liver tumors in rodents exposed to peroxisome proliferators.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7273344     DOI: 10.1093/carcin/2.7.645

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  18 in total

1.  Comparative induction of cytochrome P450IVA1 and peroxisome proliferation by ciprofibrate in the rat and marmoset.

Authors:  J M Makowska; F W Bonner; G G Gibson
Journal:  Arch Toxicol       Date:  1991       Impact factor: 5.153

2.  Role of periductal and ductular epithelial cells of the adult rat pancreas in pancreatic hepatocyte lineage. A change in the differentiation commitment.

Authors:  M S Rao; R S Dwivedi; A V Yeldandi; V Subbarao; X D Tan; M I Usman; S Thangada; M R Nemali; S Kumar; D G Scarpelli
Journal:  Am J Pathol       Date:  1989-05       Impact factor: 4.307

3.  Pancreatic hepatocytes. An in vivo model for cell lineage in pancreas of adult rat.

Authors:  J K Reddy; M S Rao; A V Yeldandi; X D Tan; R S Dwivedi
Journal:  Dig Dis Sci       Date:  1991-04       Impact factor: 3.199

4.  Time course investigation of PPARalpha- and Kupffer cell-dependent effects of WY-14,643 in mouse liver using microarray gene expression.

Authors:  Courtney G Woods; Oksana Kosyk; Blair U Bradford; Pamela K Ross; Amanda M Burns; Michael L Cunningham; Pingping Qu; Joseph G Ibrahim; Ivan Rusyn
Journal:  Toxicol Appl Pharmacol       Date:  2007-09-16       Impact factor: 4.219

5.  Deciphering diseases and biological targets for environmental chemicals using toxicogenomics networks.

Authors:  Karine Audouze; Agnieszka Sierakowska Juncker; Francisco J S S A Roque; Konrad Krysiak-Baltyn; Nils Weinhold; Olivier Taboureau; Thomas Skøt Jensen; Søren Brunak
Journal:  PLoS Comput Biol       Date:  2010-05-20       Impact factor: 4.475

6.  Time-course comparison of xenobiotic activators of CAR and PPARalpha in mouse liver.

Authors:  Pamela K Ross; Courtney G Woods; Blair U Bradford; Oksana Kosyk; Daniel M Gatti; Michael L Cunningham; Ivan Rusyn
Journal:  Toxicol Appl Pharmacol       Date:  2008-12-24       Impact factor: 4.219

Review 7.  Stem cells and liver regeneration.

Authors:  Andrew W Duncan; Craig Dorrell; Markus Grompe
Journal:  Gastroenterology       Date:  2009-05-24       Impact factor: 22.682

8.  Eicosapentaenoic acid at hypotriglyceridemic dose enhances the hepatic antioxidant defense in mice.

Authors:  A Demoz; N Willumsen; R K Berge
Journal:  Lipids       Date:  1992-12       Impact factor: 1.880

9.  Effect of dietary vitamin E on the development of altered hepatic foci and hepatic tumors induced by the peroxisome proliferator ciprofibrate.

Authors:  H P Glauert; M M Beaty; T D Clark; W S Greenwell; V Tatum; L C Chen; T Borges; T L Clark; S R Srinivasan; C K Chow
Journal:  J Cancer Res Clin Oncol       Date:  1990       Impact factor: 4.553

10.  Integrated metabolomic profiling of hepatocellular carcinoma in hepatitis C cirrhosis through GC/MS and UPLC/MS-MS.

Authors:  Asem I Fitian; David R Nelson; Chen Liu; Yiling Xu; Miguel Ararat; Roniel Cabrera
Journal:  Liver Int       Date:  2014-04-28       Impact factor: 5.828

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.